Home Healthcare Medical Devices Neurovascular Catheters Market

Neurovascular Catheters Market Size, Share & Trends Analysis Report By Type (Microcatheter, Balloon Catheter, Access Catheter, Embolization Catheter, Others), By Applications (Embolic Stroke, Brain Aneurysms, Arteriovenous Malformations, Others), By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Diagnostic Centers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Neurovascular Catheters Market Size

The global neurovascular catheters market size was valued at USD 4.03 billion in 2025 and is projected to grow from USD 4.30 billion in 2026 to USD 7.16 billion by 2034, registering a CAGR of 6.6% during the forecast period from 2026 to 2034. North America dominated the neurovascular catheters market with a market share of 39.2% in 2025.

Factors such as the Rising Prevalence of Hemorrhagic and Ischemic Stroke significantly drives the neurovascular catheters market demand by 2033. Catheters are medical devices with a tube-like structure that slide into body cavities for therapeutic or diagnostic purposes. Improved and technologically sophisticated medical devices, such as neurovascular catheters, treat various neurovascular diseases and conditions. Unwanted fluids can be removed from neurovascular organs like the carotid artery, brain, and intracranial spaces using neurovascular catheters, which aid in administering medications to the organs and diagnosing neurovascular diseases like carotid artery disease and brain aneurysms. Neurovascular catheters have gradually increased due to a significant increase in neurological procedures. Additionally, there have been several advancements in treating ischemic stroke, including flow-rerouting stents and stent retrievers assisting in the catheter industry.

Neurovascular Catheters Market Size

Download a Free Sample To learn more about this report.

Type Insights

The global market is bifurcated into microcatheter, balloon catheters, access catheters, and embolization catheters. The embolization catheter segment is the highest contributor to the market and is expected to grow at a CAGR of 6.2% during the forecast period. In order to stop the blood flow from feeding the tumor or malformation, a catheter is used to inject drugs or artificial substances known as embolic agents into the targeted blood vessel. Neurovascular embolization catheters can block blood vessels supplying a tumor or treating aneurysms, stopping or controlling abnormal bleeding. They offer better bleeding control than open surgeries and are minimally invasive procedures. The Biometrics Embolization Catheter impedes or stops blood flow to a specific body area.

Access catheters are made to locate and place a different device, catheter, or fluid inside the body. In general, applications for neurovascular access catheters include IV therapy, blood removal, and intensive care. A flexible distal access catheter can be used for neurovascular procedures to get around vascular tortuosity and boost catheter strength. A microcatheter can be advanced for embolizing intracranial arteriovenous malformations or intracranial aneurysms. It is integrated into a guiding sheath or catheter. Microcatheters can be inserted deeper into the target vessel using access catheters because they have a lubricated hydrophilic coating and a soft distal tube.

Neurovascular Catheters Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The global market is bifurcated into embolic stroke, brain aneurysms, arteriovenous malformations, and others. The brain aneurysms segment owns the highest market share and is expected to grow at a CAGR of 6.4% during the forecast period. Brain aneurysms, also known as intracranial aneurysms, are blood vessel leaks or ruptures that result in brain bleeding. Hypertension, smoking, damage to blood vessels, genetic predisposition, and complications from a few different types of blood infections are all factors that can cause intracranial aneurysms. Medical therapy, surgical clipping, endovascular therapy, or coiling without or with adjunctive devices are all options for treating an aneurysm. The market for neurovascular catheters will grow due to these devices' ability to remove or recover blood clots from aneurysms.

Strokes are characterized by a disrupted or diminished blood supply to the brain, which results in an irregular supply of oxygen and nutrients to the brain, damaging brain cells. Motor, sensory, cognitive, and visual impairment are just a few of the effects of a stroke. The most frequent result of a stroke is motor impairment, which leaves patients with movement disabilities. A subtype of ischemic stroke is embolic stroke. Recovery of lost arterial functions with the aid of stents and embolization coils is the primary goal of stroke rehabilitation. Demographic groups that are getting older and heavier over time are more likely to develop this condition. Stroke therapy involves the use of neurovascular catheters.

End-Users Insights

The global market is bifurcated into hospitals, clinics, ambulatory surgical centers, and diagnostic centers. The hospital segment is the highest contributor to the market and is expected to grow at a CAGR of 6.3% during the forecast period. The expansion of this market can be primarily attributed to the rising number of patients with neurovascular conditions like ischemic and hemorrhagic stroke, brain aneurysms, and AVM. Globally, hemorrhagic stroke has an impact on more than 15 million people. Additionally, during the forecast period, the availability of technologically advanced neurovascular catheters and favorable reimbursement policies may further boost the market growth for these catheters in hospitals. For instance, Medtronic provides comprehensive services to ensure coverage and payment for various neurovascular devices.

Clinics provide medical care or treatment that doesn't necessitate an overnight stay in a hospital or other healthcare facility. Regarding treatment and other services, clinics can be more convenient, quicker, and less expensive than hospitals. However, they frequently lack sophisticated and varied equipment in hospitals and cannot admit patients for long-term care, as with neurosurgeries. Acute minor stroke patients are not appropriate for clinics, which are only safe and effective in preventing early recurrent stroke after transient ischemic stroke. Therefore, it is anticipated that market growth shortly will be constrained by a lack of tools and qualified surgeons to perform neurovascular surgeries.

Neurovascular Catheters Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant shareholder in the global market and is expected to grow at a CAGR of 6.1% during the forecast period. The North American neurovascular catheters market includes countries such as the U.S., Mexico, and Canada. Due to rising stroke and brain aneurysms and increased demand for minimally invasive procedures, North America held a 33.57% revenue share in the global market for neurovascular catheters. Rapid technological progress is another element influencing market expansion in North America. It is forecasted that an increasing number of initiatives by various organizations will fuel neurovascular catheters market growth. Additionally, the Bee Foundation (TBF) is seeking applications for a brain aneurysm research grant, which will probably help the group reach its objective of reducing brain aneurysm-related mortality.

North America Neurovascular Catheters Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Neurovascular Catheters Market Trends

Europe is expected to grow at a CAGR of 6.5% generating USD 1.50 billion during the forecast period. The Europe market includes the UK, Germany, France, Italy, and the rest of Europe. The second-largest market share is held by Europe, which is expected to grow significantly over the forecast period. With cutting-edge infrastructure and technologies, Europe is one of the most developed regions in the world, producing substantial healthcare facilities and top-notch patient care. The demand for neurovascular catheters is rising due to rising rates of acute ischemic stroke, rising sedentary lifestyle adoption, and the entry of technologically advanced goods onto the European market. However, the absence of favorable reimbursement policies in Europe's developing nations will likely impede market expansion during the anticipated time frame.

Asia Pacific Neurovascular Catheters Market Trends

The market for neurovascular catheters in Asia-Pacific is primarily driven by an increase in the frequency of acute ischemic stroke. Additionally, emerging economies like China, Japan, South Korea, and India are anticipated to experience significant growth over the forecast period. Numerous local competitors in China and Japan may also accelerate market expansion. The lack of skilled professionals and low uptake of modern healthcare facilities in these nations may impede market expansion. It is predicted that inadequate healthcare reimbursement facilities in developing countries and low awareness among people regarding treating acute ischemic stroke, mechanical thrombectomy, and intravenous thrombolysis will restrain the market growth.

Latin America Neurovascular Catheters Market Trends

The market is forecasted to be driven by rising healthcare spending in Latin America and rising awareness of acute ischemic stroke treatment. Additionally, rising healthcare costs in Brazil and the gradual adoption of cutting-edge medical facilities could positively affect market expansion. However, the development of the market in Latin America is likely to be hampered by the absence of sufficient skilled professionals and knowledge regarding the proper treatment of acute ischemic stroke in nations like Mexico, Colombia, and Argentina. Middle Eastern countries with thriving economies include Saudi Arabia, South Africa, and the United Arab Emirates. The market's growth is anticipated to be fueled by rising rates of acute ischemic stroke in South Africa, Saudi Arabia, and the United Arab Emirates.

List of Key and Emerging Players in Neurovascular Catheters Market

Acandis GmbH
Access Vascular Inc.
Balt USA LLC
Biomerics
Concentric Medical Inc.
Imperative Care Inc
Integer Holdings Corporation
Integra LifeSciences
Medtronic Plc
Midwest Interventional Systems
Neurovas
Penumbra Inc.
Phenox GmbH
RAUMEDIC AG
Spiegelberg GmbH & Co. KG.
Stryker Corporation
Terumo Corporation
Zeus Industrial Products Inc.

Key Industry Developments

June 2026
Terumo Neuro (MicroVention) received U.S. FDA 510(k) clearance for its ISAAC Neurovascular Navigation Catheter, expanding its portfolio with an advanced navigation catheter designed for complex neurovascular interventions.
April 2026
Radical Catheter Technologies received U.S. FDA 510(k) clearance for its 6F Neurovascular Catheter, broadening its neurovascular access platform for radial access procedures and middle meningeal artery embolization.
March 2026
Toro Neurovascular received U.S. FDA 510(k) clearance for its Toro 88 Superbore Catheter and initiated its U.S. commercial launch, expanding its portfolio of large-bore neurovascular access catheters for stroke intervention.
May 2025
Crossroads Neurovascular received U.S. FDA 510(k) clearance for its PATH BGC™ Balloon Guide Catheter, expanding its neurovascular access portfolio for ischemic stroke and complex endovascular procedures.

Report Scope

Segmentation

By Type 5
  • Microcatheter
  • Balloon Catheter
  • Access Catheter
  • Embolization Catheter
  • Others
By Applications 4
  • Embolic Stroke
  • Brain Aneurysms
  • Arteriovenous Malformations
  • Others
By End-User 4
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Acandis GmbH · Access Vascular Inc. · Balt USA LLC · Biomerics · Concentric Medical Inc.
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The neurovascular catheters market size is valued at USD 4.30 Billion in 2026 and is projected to reach USD 7.16 Billion by 2034, at a CAGR of 6.6% during the forecast period 2026-2034.
North America dominated the market with a share of 39.2% in 2025.
The leading players in this market are Acandis GmbH, Access Vascular Inc., Balt USA LLC, Biomerics, Concentric Medical Inc..
The neurovascular catheters market is projected to grow at a CAGR of 6.6% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now